These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2994227)

  • 1. A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus.
    Chang RS; Lotti VJ; Monaghan RL; Birnbaum J; Stapley EO; Goetz MA; Albers-Schönberg G; Patchett AA; Liesch JM; Hensens OD
    Science; 1985 Oct; 230(4722):177-9. PubMed ID: 2994227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties.
    Goetz MA; Lopez M; Monaghan RL; Chang RS; Lotti VJ; Chen TB
    J Antibiot (Tokyo); 1985 Dec; 38(12):1633-7. PubMed ID: 3005212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
    Chang RS; Lotti VJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4923-6. PubMed ID: 3014520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
    Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asperlicin, a nonpeptidal cholecystokinin receptor antagonist, attenuates sodium taurocholate-induced acute pancreatitis in rats.
    Wisner JR; Renner IG
    Pancreas; 1988; 3(2):174-9. PubMed ID: 2453874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility.
    Bock MG; DiPardo RM; Rittle KE; Evans BE; Freidinger RM; Veber DF; Chang RS; Chen TB; Keegan ME; Lotti VJ
    J Med Chem; 1986 Oct; 29(10):1941-5. PubMed ID: 3761313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel cholecystokinin antagonists from Aspergillus alliaceus. I. Fermentation, isolation, and biological properties.
    Goetz MA; Monaghan RL; Chang RS; Ondeyka J; Chen TB; Lotti VJ
    J Antibiot (Tokyo); 1988 Jul; 41(7):875-7. PubMed ID: 3417561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Structure elucidation.
    Liesch JM; Hensens OD; Springer JP; Chang RS; Lotti VJ
    J Antibiot (Tokyo); 1985 Dec; 38(12):1638-41. PubMed ID: 3841533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.
    Gully D; Fréhel D; Marcy C; Spinazzé A; Lespy L; Neliat G; Maffrand JP; Le Fur G
    Eur J Pharmacol; 1993 Feb; 232(1):13-9. PubMed ID: 7681406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
    Chang RS; Lotti VJ; Chen TB; Kunkel KA
    Mol Pharmacol; 1986 Sep; 30(3):212-7. PubMed ID: 3018478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asperlicin antagonizes stimulatory effects of cholecystokinin on isolated islets.
    Zawalich WS; Diaz VA
    Am J Physiol; 1987 Mar; 252(3 Pt 1):E370-4. PubMed ID: 3548432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.
    Lotti VJ; Chang RS
    Eur J Pharmacol; 1989 Mar; 162(2):273-80. PubMed ID: 2721567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist.
    Setnikar I; Bani M; Cereda R; Chisté R; Makovec F; Pacini MA; Revel L; Rovati LC; Rovati LA
    Arzneimittelforschung; 1987 Jun; 37(6):703-7. PubMed ID: 3663268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin and gastrin peptides stimulate ODC activity in a rat pancreatic cell line.
    Scemama JL; De Vries L; Pradayrol L; Seva C; Tronchere H; Vaysse N
    Am J Physiol; 1989 May; 256(5 Pt 1):G846-50. PubMed ID: 2719109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M; Niederau C; Strohmeyer G; Grendell JH
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new simple mouse model for the in vivo evaluation of cholecystokinin (CCK) antagonists: comparative potencies and durations of action of nonpeptide antagonists.
    Lotti VJ; Cerino DJ; Kling PJ; Change RS
    Life Sci; 1986 Nov; 39(18):1631-8. PubMed ID: 3773639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.